Galantamine / MDA Cancer Research Results

Gala, Galantamine: Click to Expand ⟱

Features:

Galantamine
FDA approved drug for mild to moderate Alzheimer's Disease
- AChE inhibitor (reversible, competitive)
-May improve memory, cognition, and behavior

MDA, Serum malondialdehyde: Click to Expand ⟱

Source:

Type:

MDA : malondialdehyde. The level of oxidative stress can be measured by assessing the MDA levels.
Since MDA is highly cytotoxic and carcinogenic agent it is frequently used as a biomarker of oxidative stress during major health problems such as cancer, etc.
Malondialdehyde (MDA) is the most widely used agent to estimate the extent of lipid peroxidation. Timely diagnosis of the condition followed by supplementation with antioxidants like beta-carotene, pro-vitamin A, vitamin A, vitamin C, vitamin E, lipoic acid, zinc, selenium, and spirulina can prevent potentially malignant disorders.
MDA is a lipid peroxidation marker

Scientific Papers found: Click to Expand⟱

3751-

CUR,

Gala,

A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders

in-vivo,

AD,

mice

*AChE↓, *MDA↑, *GSH↑, *BBB↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Total Targets: 0

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

GSH↑, 1, MDA↑, 1,

Barriers & Transport ⓘ

BBB↑, 1,

Synaptic & Neurotransmission ⓘ

AChE↓, 1,
Total Targets: 4

Scientific Paper Hit Count for: MDA, Serum malondialdehyde

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells